help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nestler, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nestler, J. E.

Endocrinology, Vol 132, 566-570, Copyright © 1993 by Endocrine Society


ARTICLES

Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts

JE Nestler
Division of Endocrinology and Metabolism, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.

Interleukin-1 (IL-1) is a multifunctional immunoregulatory peptide. Evidence suggests that IL-1 of either decidual or placental origin may serve a role in the paracrine/autocrine regulation of placental function, and the present studies were conducted to define the effects of IL-1 on the aromatase activity of human placental cytotrophoblasts. When freshly isolated cytotrophoblasts were incubated in medium supplemented with androstenedione, treatment with human IL-1 beta (hIL- 1 beta) consistently increased the aromatization of this androgen to estrogens. In a representative experiment, hIL-1 beta (50 ng/ml) increased aromatization at 4 and 24 h by 145% (P < 0.001) and 78% (P < 0.05), respectively. This was indeed due to increased hIL-1 beta- mediated estrogen biosynthesis, rather than to decreased catabolism of estrogens, since cytotrophoblasts incubated in the presence of hIL-1 beta for 24 h exhibited 65% greater aromatase activity than control cells (P < 0.0001), as quantitated by the specific release of 3H2O from [3H] androstenedione. Stimulation of aromatase activity by hIL-1 beta was concentration dependent and saturable, and significant (P < 0.05) stimulation could be demonstrated at a hIL-1 beta concentration as low as 20 ng/ml. In time-course studies, significant stimulation of the conversion of androstenedione to estrogens by hIL-1 beta could be detected as early as after 4 h of treatment and persisted for at least 24 h. Human IL-1 alpha stimulated the conversion of androstenedione to estrogens to an extent similar to that of hIL-1 beta, whereas the effects of murine IL-1 beta on aromatase activity were inconsistent. To determine whether endogenous IL-1 beta produced by cytotrophoblasts could itself act to stimulate aromatase activity, a neutralizing anti- IL-1 beta antibody was employed. When cells were incubated in the presence of anti-IL-1 beta antibody for either 4 or 24 h, the conversion of androstenedione to estrogens was significantly decreased compared to that in control incubations, whereas aromatase activity was not altered by the addition of nonimmune rabbit immunoglobulin G. These findings suggest that 1) both hIL-1 beta and hIL-1 alpha stimulate the aromatase activity of human cytotrophoblasts; and 2) endogenously produced IL-1 beta may function physiologically to enhance cytotrophoblastic aromatase activity.


This article has been cited by other articles:


Home page
ReproductionHome page
L. Blomberg, K. Hashizume, and C. Viebahn
Blastocyst elongation, trophoblastic differentiation, and embryonic pattern formation
Reproduction, February 1, 2008; 135(2): 181 - 195.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. A. Sato and M. D. Mitchell
Molecular inhibition of histone deacetylation results in major enhancement of the production of IL-1beta in response to LPS
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E490 - E493.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Sun and L. Myatt
Enhancement of Glucocorticoid-Induced 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression by Proinflammatory Cytokines in Cultured Human Amnion Fibroblasts
Endocrinology, December 1, 2003; 144(12): 5568 - 5577.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. W. Ross, J. R. Malayer, J. W. Ritchey, and R. D. Geisert
Characterization of the Interleukin-1{beta} System During Porcine Trophoblastic Elongation and Early Placental Attachment
Biol Reprod, October 1, 2003; 69(4): 1251 - 1259.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M. CUTOLO and R. H STRAUB
Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: implications in rheumatoid arthritis
Ann Rheum Dis, September 1, 2000; 59(9): 657 - 661.
[Full Text]


Home page
Reproductive SciencesHome page
D. T. Vandermolen, S. W. Kauma, and T. T. Turner
Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} Stimulate Granulocyte Colony-Stimulating Factor Production by Placental Villous Core Mesenchymal Cells
Reproductive Sciences, July 1, 1996; 3(4): 172 - 178.
[Abstract] [PDF]


Home page
ScienceHome page
J. Cross, Z Werb, and S. Fisher
Implantation and the placenta: key pieces of the development puzzle
Science, December 2, 1994; 266(5190): 1508 - 1518.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society